Harmony Biosciences Profit Falls Despite 12% Sales Growth
PLYMOUTH MEETING, PA — Harmony Biosciences Holdings Inc. (Nasdaq: HRMY) reported a decline in third-quarter profit despite a 12% increase in sales of its narcolepsy treatment WAKIX, as higher licensing …
Harmony Biosciences Profit Falls Despite 12% Sales Growth Read More